429 total citations 20 papers, 371 citations indexed
About
van Oosterom At is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, van Oosterom At has authored 20 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in van Oosterom At's work include Testicular diseases and treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Sarcoma Diagnosis and Treatment (3 papers) van Oosterom At is often cited by papers focused on Testicular diseases and treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Sarcoma Diagnosis and Treatment (3 papers) van Oosterom At collaborates with scholars based in Netherlands, Belgium and France van Oosterom At's co-authors include Frits J. Berends, Lohman Ph, L. Dirix, J. Hermans, R R Hall, Y Matsumura, Hideyuki Akaza, Derek Raghavan, A Yagoda and Philip Bedford and has published in prestigious journals such as PubMed.
Citations per year, relative to van Oosterom At van Oosterom At (= 1×)
peers
Dava J. Garcia
Countries citing papers authored by van Oosterom At
Since
Specialization
Citations
This map shows the geographic impact of van Oosterom At's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Oosterom At with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Oosterom At more than expected).
This network shows the impact of papers produced by van Oosterom At. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Oosterom At. The network helps show where van Oosterom At may publish in the future.
Co-authorship network of co-authors of van Oosterom At
This figure shows the co-authorship network connecting the top 25 collaborators of van Oosterom At.
A scholar is included among the top collaborators of van Oosterom At based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with van Oosterom At. van Oosterom At is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Wynendaele, Wim & van Oosterom At. (1999). Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?. PubMed. 9(3). 212–21.1 indexed citations
2.
Dalesio, O., Sjoerd Rodenhuis, R. Dubbelman, et al.. (1992). Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.. PubMed. 19(1 Suppl 2). 99–101.10 indexed citations
3.
Akaza, Hideyuki, et al.. (1990). Objective response criteria in prostate cancer.. PubMed. 357. 193–7.1 indexed citations
4.
Dirix, L. & van Oosterom At. (1989). The role of ifosfamide in the treatment of sarcomas.. PubMed. 16(1 Suppl 3). 39–45.9 indexed citations
5.
Bedford, Philip, et al.. (1988). Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.. PubMed. 321–8.13 indexed citations
6.
Stoter, G., et al.. (1988). A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.. PubMed. 269. 381–93.5 indexed citations
7.
At, van Oosterom, et al.. (1988). Objective response criteria in phase II and phase III studies.. PubMed. 269. 243–60.4 indexed citations
8.
At, van Oosterom, et al.. (1987). cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).. PubMed. 47(11). 3000–4.230 indexed citations
9.
At, van Oosterom, et al.. (1987). Intraperitoneal chemotherapy in ovarian carcinoma.. PubMed. 30(1-2). 94–103.5 indexed citations
10.
At, van Oosterom, Hideyuki Akaza, R R Hall, et al.. (1986). Response criteria phase II/phase III invasive bladder cancer.. PubMed. 221. 301–10.19 indexed citations
11.
At, van Oosterom, et al.. (1986). The human tumour colony-forming assay using fresh specimens.. PubMed. 29(6). 180–8.1 indexed citations
12.
Mangioni, C., et al.. (1985). Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.. PubMed. 201. 225–37.5 indexed citations
13.
At, van Oosterom, et al.. (1985). CA 125 and TPA as markers in ovarian carcinoma.. PubMed. 28(12). 536–40.4 indexed citations
14.
At, van Oosterom, et al.. (1985). Combination chemotherapy preceding surgery in osteogenic sarcoma.. PubMed. 201. 53–7.5 indexed citations
15.
At, van Oosterom, et al.. (1985). Plasma levels during intravesical instillation of mitomycin-C.. PubMed. 185B. 81–93.5 indexed citations
16.
At, van Oosterom, et al.. (1985). Immunohistochemical localization and chromatographic characterization of human chorionic gonadotropin in a bladder carcinoma.. PubMed. 109(11). 1046–8.23 indexed citations
17.
At, van Oosterom, et al.. (1984). Treatment of seminomas with chemotherapy.. PubMed. 153. 103–9.4 indexed citations
18.
Hermans, J., et al.. (1983). Pharmacokinetics of the cytostatic drugs used in the CMF-regimen.. PubMed. 3(4). 269–71.14 indexed citations
19.
Driessen, O., et al.. (1982). Determination of plasma concentrations of underivatized cyclophosphamide by capillary gas chromatography.. PubMed. 3(6). 377–84.8 indexed citations
20.
At, van Oosterom, et al.. (1980). A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.. PubMed. Suppl 1. 275–6.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.